ATORVASTATIN CALCIUM
- Product NDC
- 43353-120
- 11-digit product format
- 433530120
- Labeler code
- 43353
- Product ID
- 43353-120_67dce28b-a634-42eb-b565-93d513ab9b10
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA020702
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2013-01-28
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43353-120-45 | ATORVASTATIN CALCIUM | 45 in 1 BOTTLE | TABLET, FILM COATED | 45 | | 4 |
| 43353-120-60 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-120 | ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 4 | Legacy NDC, 2 package rows | 20191219_b0f54cad-3ff2-4c3b-9ef1-b888c4d6c25c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-120-45 | 43353012045 | 45 TABLET, FILM COATED in 1 BOTTLE (43353-120-45) | 2015-11-04 | 0000-00-00 | No | No | Current |
| 43353-120-60 | 43353012060 | 90 TABLET, FILM COATED in 1 BOTTLE (43353-120-60) | 2016-01-13 | 0000-00-00 | No | No | Current |